Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea: Device Systems, Surgical Technique, and Clinical Outcomes

Background and Objectives: Hypoglossal nerve stimulation (HGNS) has emerged as an effective alternative therapy for patients with obstructive sleep apnea (OSA) who fail or cannot tolerate positive airway pressure (PAP) therapy. This review summarizes the system design, implantation techniques, indications, contraindications, and clinical outcomes of currently available HGNS systems, focusing on the Inspire® upper airway stimulation system and the Genio® system. Materials and Methods: A comprehensive synthesis of device architecture, surgical procedures, patient selection criteria, and evidence from major clinical trials was performed. Comparative evaluation included device components, stimulation principles, perioperative considerations, and long-term efficacy and safety profiles. Results: The Inspire® system employs unilateral stimulation via an implantable pulse generator, respiratory sensing lead, and stimulation lead, requiring multistep implantation with selective medial branch of hypoglossal nerve targeting. In contrast, the Genio® system provides bilateral, lead-less stimulation through a single submental implant powered externally, eliminating the need for thoracic leads and intramuscular cuff dissection. Clinical studies including STAR, ADHERE, and BLAST-OSA demonstrate significant reductions in apnea–hypopnea index, oxygen desaturation index and daytime sleepiness, with high adherence rates and sustained long-term benefits. Complications are generally mild, with low rates of device-related serious adverse events. Conclusion: HGNS represents a validated, durable, and patient-centric treatment modality for moderate-to-severe OSA, particularly in PAP-intolerant patients without complete concentric palatal collapse. Inspire® and Genio® system differ substantially in surgical approach and device design, offering complementary therapeutic options tailored to patient anatomy, comorbidities, and lifestyle considerations. Continued refinement of technology and expanding indications are expected to broaden clinical applications in future.

Authors

Publication Details

Journal
Journal of Clinical Otolaryngology Head and Neck Surgery
Published
2025-12-01
DOI
https://doi.org/10.35420/jcohns.2025.36.4.72
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea: Device Systems, Surgical Technique, and Clinical Outcomes

Seung Hoon Lee
Journal of Clinical Otolaryngology Head and Neck Surgery
Obstructive Sleep Apnea Research
article

Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea: Device Systems, Surgical Technique, and Clinical Outcomes

Seung Hoon Lee
article en

Abstract

Background and Objectives: Hypoglossal nerve stimulation (HGNS) has emerged as an effective alternative therapy for patients with obstructive sleep apnea (OSA) who fail or cannot tolerate positive airway pressure (PAP) therapy. This review summarizes the system design, implantation techniques, indications, contraindications, and clinical outcomes of currently available HGNS systems, focusing on the Inspire® upper airway stimulation system and the Genio® system. Materials and Methods: A comprehensive synthesis of device architecture, surgical procedures, patient selection criteria, and evidence from major clinical trials was performed. Comparative evaluation included device components, stimulation principles, perioperative considerations, and long-term efficacy and safety profiles. Results: The Inspire® system employs unilateral stimulation via an implantable pulse generator, respiratory sensing lead, and stimulation lead, requiring multistep implantation with selective medial branch of hypoglossal nerve targeting. In contrast, the Genio® system provides bilateral, lead-less stimulation through a single submental implant powered externally, eliminating the need for thoracic leads and intramuscular cuff dissection. Clinical studies including STAR, ADHERE, and BLAST-OSA demonstrate significant reductions in apnea–hypopnea index, oxygen desaturation index and daytime sleepiness, with high adherence rates and sustained long-term benefits. Complications are generally mild, with low rates of device-related serious adverse events. Conclusion: HGNS represents a validated, durable, and patient-centric treatment modality for moderate-to-severe OSA, particularly in PAP-intolerant patients without complete concentric palatal collapse. Inspire® and Genio® system differ substantially in surgical approach and device design, offering complementary therapeutic options tailored to patient anatomy, comorbidities, and lifestyle considerations. Continued refinement of technology and expanding indications are expected to broaden clinical applications in future.

Journal of Clinical Otolaryngology Head and Neck SurgeryVol. 36(4)
Openalex Percentile: Top 31%
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.